TWI407915B - - Google Patents
Info
- Publication number
- TWI407915B TWI407915B TW100121652A TW100121652A TWI407915B TW I407915 B TWI407915 B TW I407915B TW 100121652 A TW100121652 A TW 100121652A TW 100121652 A TW100121652 A TW 100121652A TW I407915 B TWI407915 B TW I407915B
- Authority
- TW
- Taiwan
- Prior art keywords
- ile
- leu
- soy protein
- tilde
- val
- Prior art date
Links
- 108010073771 Soybean Proteins Proteins 0.000 abstract 4
- 238000006460 hydrolysis reaction Methods 0.000 abstract 4
- 229940001941 soy protein Drugs 0.000 abstract 4
- 230000007062 hydrolysis Effects 0.000 abstract 3
- 238000006243 chemical reaction Methods 0.000 abstract 2
- 108010007119 flavourzyme Proteins 0.000 abstract 2
- 239000003531 protein hydrolysate Substances 0.000 abstract 2
- BBQABUDWDUKJMB-LZXPERKUSA-N Ile-Ile-Ile Chemical compound CC[C@H](C)[C@H]([NH3+])C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C([O-])=O BBQABUDWDUKJMB-LZXPERKUSA-N 0.000 abstract 1
- TWPSALMCEHCIOY-YTFOTSKYSA-N Ile-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O)N TWPSALMCEHCIOY-YTFOTSKYSA-N 0.000 abstract 1
- GAZGFPOZOLEYAJ-YTFOTSKYSA-N Ile-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N GAZGFPOZOLEYAJ-YTFOTSKYSA-N 0.000 abstract 1
- HPCFRQWLTRDGHT-AJNGGQMLSA-N Ile-Leu-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O HPCFRQWLTRDGHT-AJNGGQMLSA-N 0.000 abstract 1
- SEMUSFOBZGKBGW-YTFOTSKYSA-N Leu-Ile-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O SEMUSFOBZGKBGW-YTFOTSKYSA-N 0.000 abstract 1
- KUIDCYNIEJBZBU-AJNGGQMLSA-N Leu-Ile-Leu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O KUIDCYNIEJBZBU-AJNGGQMLSA-N 0.000 abstract 1
- FAELBUXXFQLUAX-AJNGGQMLSA-N Leu-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C FAELBUXXFQLUAX-AJNGGQMLSA-N 0.000 abstract 1
- DNDWZFHLZVYOGF-KKUMJFAQSA-N Leu-Leu-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O DNDWZFHLZVYOGF-KKUMJFAQSA-N 0.000 abstract 1
- 108010009736 Protein Hydrolysates Proteins 0.000 abstract 1
- 108010049589 leucyl-leucyl-leucine Proteins 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000005215 recombination Methods 0.000 abstract 1
- 230000006798 recombination Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW100121652A TW201300027A (zh) | 2011-06-21 | 2011-06-21 | 促肪解大豆胜肽之最適水解條件、序列及其應用 |
| US13/337,136 US20120329985A1 (en) | 2011-06-21 | 2011-12-25 | Optimal hydolysis conditions of soy protein to produce peptides with lipolysis-stimulating activity and their sequencing and use thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW100121652A TW201300027A (zh) | 2011-06-21 | 2011-06-21 | 促肪解大豆胜肽之最適水解條件、序列及其應用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201300027A TW201300027A (zh) | 2013-01-01 |
| TWI407915B true TWI407915B (enExample) | 2013-09-11 |
Family
ID=47362453
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW100121652A TW201300027A (zh) | 2011-06-21 | 2011-06-21 | 促肪解大豆胜肽之最適水解條件、序列及其應用 |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | US20120329985A1 (enExample) |
| TW (1) | TW201300027A (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI531373B (zh) * | 2014-06-24 | 2016-05-01 | Use of peptides for the preparation of pharmaceutical compositions for the prevention or treatment of heart-related diseases and nutritional supplements containing the peptides | |
| CN104109706A (zh) * | 2014-07-24 | 2014-10-22 | 南京财经大学 | 一种菜籽抗氧化肽的分离纯化方法 |
| TWI580690B (zh) * | 2014-08-25 | 2017-05-01 | The use of multidipins for the manufacture of pharmaceutical compositions for in vivo multipurpose effects | |
| CN112316109A (zh) * | 2020-12-02 | 2021-02-05 | 深圳市图微安创科技开发有限公司 | 多肽at03在治疗糖尿病肾病药物中的应用 |
| CN112656934A (zh) * | 2021-01-22 | 2021-04-16 | 深圳市图微安创科技开发有限公司 | 多肽at03在治疗原发性胆汁性胆管炎药物中的应用 |
-
2011
- 2011-06-21 TW TW100121652A patent/TW201300027A/zh not_active IP Right Cessation
- 2011-12-25 US US13/337,136 patent/US20120329985A1/en not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| 趙佳宏，大豆蛋白水解物對3T3-L1脂肪細胞具有促進脂解活性之研究，東海大學碩士論文，98年7月 * |
Also Published As
| Publication number | Publication date |
|---|---|
| TW201300027A (zh) | 2013-01-01 |
| US20120329985A1 (en) | 2012-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1125302T1 (el) | Συναγωνιστες γλυκαγονης και glp-1 για την αγωγη της παχυσαρκιας | |
| MX2017005268A (es) | Tripeptidil peptidasas tolerantes a prolina y usos de las mismas. | |
| WO2015027259A3 (de) | Polypeptid zur hydrolytischen spaltung von zearalenon und/oder zearalenon-derivaten, isoliertes polynukleotid davon sowie einen zusatzstoff enthaltendes polypeptid, verwendung desselben sowie verfahren | |
| MX2017009595A (es) | Compuestos antisenescentes y usos de los mismos. | |
| MX2011012906A (es) | Produccion recombinante de peptidos. | |
| WO2008074840A3 (en) | Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders | |
| WO2012014214A3 (en) | Peptides derived from plasminogen activator inhibitor-1 (pai-1) for the treatment of hypertension | |
| TWI407915B (enExample) | ||
| MX2008012748A (es) | Un proceso para la concentracion de un polipeptido. | |
| MX2013010019A (es) | Metodo para aislamiento de osteopontina utilizando alimentos concentrados. | |
| PH12014502764A1 (en) | Method | |
| CY1118856T1 (el) | Εμβολιο pcsk9 | |
| SA112340123B1 (ar) | عملية للحصول على نواتج انحلال مائي لبروتين الأرز | |
| MX2016007407A (es) | Peptidos resistentes a proteasa. | |
| MX354156B (es) | Dipeptido que comprende un aminoacido no proteogenico. | |
| NZ742745A (en) | Variants of chymosin with improved milk-clotting properties | |
| MX2017008908A (es) | Proceso para la hidrólisis de queratina empleando proteasas. | |
| AR128395A2 (es) | Péptidos novedosos capaces de inducir la formación de anticuerpos contra pcsk9 | |
| MX2015010078A (es) | Uso de polipeptidos con actividad proteasa en alimentos para animales. | |
| MX366493B (es) | Composiciones y su uso en el tratamiento de cánceres cerebrales. | |
| EA201692439A1 (ru) | Пролин-специфичная эндопротеаза и ее применение | |
| MX343295B (es) | Polipeptidos que tienen actividad de endopeptidasa y polinucleotidos que codifican para los mismos. | |
| MX2016007109A (es) | Proteina estructurante de hielo. | |
| MY204884A (en) | Peptide for treating age-related macular degeneration | |
| NZ709120A (en) | Beta-hexosyl-transferases and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |